cis-1,2,6-Trimethyl-4-(4-nitrophenyl)piperazine → 4-(cis-3,4,5-Trimethyl-piperazin-1-yl)-phenylamine
반응식
C[C@H]1CN(C)[C@H](C)CN1C1C=CC(N)=CC=1.[CH3:17][N:18]1[C@H:23]([CH3:24])[CH2:22][N:21]([C:25]2[CH:30]=[CH:29][C:28]([N+:31]([O-])=O)=[CH:27][CH:26]=2)[CH2:20][C@@H:19]1[CH3:34]>[Pd]>[CH3:34][C@H:19]1[N:18]([CH3:17])[C@@H:23]([CH3:24])[CH2:22][N:21]([C:25]2[CH:26]=[CH:27][C:28]([NH2:31])=[CH:29][CH:30]=2)[CH2:20]1참가 물질
4
실험 절차
Using the method described above for the synthesis of racemic-4-(trans-2,4,5-Trimethyl-piperazin-1-yl)-phenylamine, treatment of cis-1,2,6-trimethyl-4-(4-nitrophenyl)piperazine (1.28 g, 5.13 mmol) with H2 and 10% Pd/C (130 mg) provided crude 4-(cis-3,4,5-Trimethyl-piperazin-1-yl)-phenylamine (1.18 g, 101% recovery, >85% purity as determined by LC/MS analysis @ UV 254 nm detection). The crude product was used in the next step without further purification. LCMS-ESI (m/z): calcd for C13H21N3, 219; [M+H]+ found, 220.
출처 및 근거
- ORD 기록
- ord-dc1141a6527141fb8e798ed9d77e1e77
- 출처 데이터셋
- uspto-grants-2011_07
- 특허 번호
- US07977352B2
반응 노트
불러오는 중…